GW Pharmaceuticals Plc is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“This research has shown that CBD has significant anti-epileptiform and anticonvulsant activity using a variety of in vitro and in vivo models and that it has the ability to treat seizures in acute animal models of epilepsy with significantly fewer side effects than existing AEDs.” Read the full document
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. The company operates through the following segments: Commercial, Sativex Research & Development, and Pipeline Research & Development. The company was founded by Geoffrey W. Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. [Source: MarketWatch]
Company Website: https://www.gwpharm.com